(CLOZ) Panagram Bbb-B Clo - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81752T5285

Collateralized Loan Obligations, Secured Debt, Bank Loans

Description: CLOZ Panagram Bbb-B Clo

The Panagram BBB-B CLO ETF (NYSE ARCA:CLOZ) is an actively managed exchange-traded fund that focuses on investing at least 80% of its net assets in collateralized loan obligations (CLOs) rated between BBB+ and B- by a nationally recognized statistical rating organization (NRSRO). This investment strategy targets a specific segment of the credit market, providing exposure to a diversified portfolio of leveraged loans.

As a non-diversified ETF, CLOZ is more susceptible to significant price movements due to its concentrated investment approach. The funds underlying assets are CLOs, which are securities backed by a pool of loans made to corporations. These loans are typically issued by companies with lower credit ratings, making them riskier but also potentially more rewarding.

From a technical analysis perspective, the current price of 26.81 is near the 52-week high, indicating a strong upward trend. The short-term moving averages (SMA20: 26.70, SMA50: 26.29) are also trending upwards, suggesting continued momentum. The average true range (ATR) of 0.10 represents a relatively low volatility, which may be attractive to investors seeking more stable returns.

Combining the technical and fundamental data, we can forecast that CLOZ may continue to experience a positive trend in the near term, driven by its strong technical indicators and the overall demand for CLOs in the market. With an AUM of $766.42M USD, the fund has a substantial asset base, which can help to reduce costs and increase its appeal to investors. However, investors should be cautious of the potential risks associated with CLOs, including credit risk and interest rate risk.

Based on the available data, a potential forecast for CLOZ is a continued upward trend, with a potential target price of 27.50 in the next few weeks, driven by the ongoing demand for CLOs and the funds strong technical indicators. However, investors should closely monitor the funds performance and adjust their strategies accordingly, as the CLO market can be subject to various market and economic factors.

CLOZ ETF Overview

Market Cap in USD 818m
Category Bank Loan
TER 0.51%
IPO / Inception 2023-01-23

CLOZ ETF Ratings

Growth Rating 41.5
Fundamental 45.0%
Dividend Rating 59.3
Rel. Strength 16.0
Analysts -
Fair Price Momentum 28.08 USD
Fair Price DCF -

CLOZ Dividends

Dividend Yield 12m 8.37%
Yield on Cost 5y 10.95%
Annual Growth 5y 2.59%
Payout Consistency 100.0%
Payout Ratio %

CLOZ Growth Ratios

Growth Correlation 3m 96.3%
Growth Correlation 12m 86.8%
Growth Correlation 5y 99.1%
CAGR 5y 12.00%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m 1.07
Alpha 2.48
Beta 0.170
Volatility 3.39%
Current Volume 341.8k
Average Volume 20d 317.7k
Stop Loss 25.9 (-3.2%)

ValueRay F-Score (Strict, 0-100) 45.00

1. Piotroski 0.0pt = -5.0
2. FCF Yield data missing
3. FCF Margin data missing
4. Debt/Equity data missing
5. Debt/Ebitda data missing
6. ROIC - WACC data missing
7. RoE data missing
8. Revenue Trend data missing
9. Revenue CAGR data missing
10. EPS Trend data missing
11. EPS CAGR data missing
What is the price of CLOZ shares?
As of August 12, 2025, the stock is trading at USD 26.77 with a total of 341,794 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.86%, over three months by +2.66% and over the past year by +9.46%.
Is Panagram Bbb-B Clo a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Panagram Bbb-B Clo (NYSE ARCA:CLOZ) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.00 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLOZ is around 28.08 USD . This means that CLOZ is currently overvalued and has a potential downside of 4.89%.
Is CLOZ a buy, sell or hold?
Panagram Bbb-B Clo has no consensus analysts rating.
What are the forecasts for CLOZ share price target?
According to our own proprietary Forecast Model, CLOZ Panagram Bbb-B Clo will be worth about 30.8 in August 2026. The stock is currently trading at 26.77. This means that the stock has a potential upside of +14.9%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 30.8 14.9%

CLOZ Fundamental Data Overview

Market Cap USD = 818.1m (818.1m USD * 1.0 USD.USD)
 CCE Cash And Equivalents = unknown
 Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
 Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
 Long Term Debt = unknown (none)
 Short Term Debt = unknown (none)
 Debt = unknown
 Net Debt = unknown
 Enterprise Value = 818.1m USD (818.1m + (null Debt) - (null CCE))
 Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
 FCF Yield = none (FCF TTM 0.0 / Enterprise Value 818.1m)
 FCF Margin = unknown (Revenue TTM is 0)
 Net Margin = unknown
 Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
 Tobins Q-Ratio = unknown (Enterprise Value 818.1m / Book Value Of Equity 0.0)
 Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
 Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
 Debt / Equity = unknown Debt (none)
 Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
 Debt / FCF = none (Debt none / FCF TTM 0.0)
 Total Stockholder Equity = unknown
 RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
 RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
 RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
 WACC = unknown (E(818.1m)/V(0.0) * Re(6.64%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
 Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
 Fair Price DCF = unknown (Cash Flow 0.0)


Additional Sources for CLOZ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle